Evidence map›Paper›PMID 38530977›Full record

ArticleBioinformatics (Oxford, England)2024

HyperTMO: a trusted multi-omics integration framework based on hypergraph convolutional network for patient classification.

Haohua Wang, Kai Lin, Qiang Zhang, Jinlong Shi, Xinyu Song, Jue Wu, Chenghui Zhao, Kunlun He

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Haohua WangSchool of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.ORCID 0000-0001-9835-0401
Kai LinSchool of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.
Qiang ZhangSchool of Computer Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.
Jinlong ShiResearch Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.ORCID 0000-0003-2674-8685
Xinyu SongResearch Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.ORCID 0000-0002-1905-3503
Jue WuResearch Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
Chenghui ZhaoResearch Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.
Kunlun HeResearch Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing 100039, China.ORCID 0000-0002-3335-5700
Chinese PLA General Hospital · CNDalian University of Technology · CN

Funding

Fundamental Research Funds for the Central Universities DUT21TD107LiaoNing Revitalization Talents Program XLYC2008017
6 · The paper itself

Abstract

motivationThe rapid development of high-throughput biomedical technologies can provide researchers with detailed multi-omics data. The multi-omics integrated analysis approach based on machine learning contributes a more comprehensive perspective to human disease research. However, there are still significant challenges in representing single-omics data and integrating multi-omics information.

resultsThis article presents HyperTMO, a Trusted Multi-Omics integration framework based on Hypergraph convolutional network for patient classification. HyperTMO constructs hypergraph structures to represent the association between samples in single-omics data, then evidence extraction is performed by hypergraph convolutional network, and multi-omics information is integrated at an evidence level. Last, we experimentally demonstrate that HyperTMO outperforms other state-of-the-art methods in breast cancer subtype classification and Alzheimer's disease classification tasks using multi-omics data from TCGA (BRCA) and ROSMAP datasets. Importantly, HyperTMO is the first attempt to integrate hypergraph structure, evidence theory, and multi-omics integration for patient classification. Its accurate and robust properties bring great potential for applications in clinical diagnosis. AVAILABILITY AND IMPLEMENTATION: HyperTMO and datasets are publicly available at https://github.com/ippousyuga/HyperTMO.

Indexed as

Alzheimer DiseaseBreast NeoplasmsBreastFemaleHumansMachine LearningMultiomics

Identifiers

PMID38530977
PMCPMC11212491
OpenAlexW4393185961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.